Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TMOD3 | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
mRNA | RHOC | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-05 |
mRNA | ZBTB18 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
mRNA | RALB | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |
mRNA | FAM129B | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
mRNA | RPS6KA1 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
mRNA | HNRNPUL1 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
mRNA | PTRH2 | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |
mRNA | ROBO1 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
mRNA | KLHDC3 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |